Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,586.40
(
0.12%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
101.39
(
-0.14%
)
Bitcoin
77,866.20
(
-1.00%
)
News Focus
News Focus
Post# of 5030883
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Gator44

Send PM Follow Ignore
Followers 33
Posts 2412
Boards Moderated 0
Alias Born 05/29/2005

Gator44

Member Level

Re: knrorrel post# 5007005

Tuesday, 07/15/2025 6:09:00 PM

Tuesday, July 15, 2025 6:09:00 PM

Post# of 5030883
IXHL .35

RePOSA, a global Phase 2/3 clinical trial is underway, evaluating IHL-42X in individuals with OSA who are either non-compliant, intolerant, or naïve to positive airway pressure devices, including CPAP, with the Phase 2 portion conducted in the United States. A topline readout from the U.S. Phase 2 portion is anticipated in July 2025.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today